Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Mar 8, 2011

Premium

Daniel Von Hoff, physician-in-chief at the Translational Genomics Research Institute, was presented with the Scripps Genomic Medicine Award last week at the annual Future of Genomic Medicine conference.

In presenting the award, Eric Topol, director of the Scripps Translational Science Institute, cited Von Hoff's "pioneering efforts" in sequencing the genomes of patients with rare cancers in order to determine the best course of treatment.


John Quackenbush of the Dana-Farber Cancer Institute has been awarded a $4 million fellowship by Australia's National Health and Medical Research Council to study chemotherapy-resistant ovarian cancers. He will join Sean Grimmond's team at the University of Queensland's Center for Medical Genomics, the largest genome sequencing facility in Australia.

Quackenbush is a professor of computational biology and bioinformatics at Dana-Farber and has been working on developing better computational methods to interpret sequence data, particularly in cancer. He also participated in the Human Genome Project.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.